VIKING THERAPEUTICS INC (VKTX)
NASDAQ • Healthcare
$33.36
-$0.26 (-0.8%)
Market open
Last close at August 18, 2026 at 20:00 UTC
Fundamentals Charts
About VIKING THERAPEUTICS INC
Name
VIKING THERAPEUTICS INC
CEO
Brian Lian
Website
Industry
Healthcare
Year Founded
2012
Employees
65
Viking Therapeutics, Inc. is a Nasdaq-listed healthcare company in biotechnology focused on clinical-stage drug development for metabolic and endocrine disorders. Trading on NASDAQ as VKTX, it advances a pipeline of investigational therapies rather than marketed products, with programs aimed at liver disease, diabetes, post-surgical recovery, and X-linked adrenoleukodystrophy.
Fundamentals & Financials
Revenue (TTM)
$0
Net Income (TTM)
-$534.7M
EPS (TTM)
-$4.66
ROA (TTM)
-102.47%
Current Ratio
4.72
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Stay Ahead of the Market
Get premium market insights delivered directly to your inbox.
Quote Summary
Previous CloseDay Range$33.37$33 - $33.94
52 Week RangeAvg. Volume$22.96 - $43.151.9M
Market Cap$3.9B
VKTX Headlines
Valuation Gaps Emerge Across Key Mid‑Cap Stocks
February 16, 2026
7 min read
Peers & Related Assets
PRAXPRAXIS PRECISION MEDICINES INC
$369.84-1.7%
KYMRKYMERA THERAPEUTICS INC
$121.38-0.0%
IMVTIMMUNOVANT INC
$44.3+1.4%
CRNXCRINETICS PHARMACEUTICALS INC
$84.72-0.0%
LGNDLIGAND PHARMACEUTICALS INC
$287.59-1.4%
ACADACADIA PHARMACEUTICALS INC
$30.18+4.0%
AKROAkero Therapeutics, Inc.
NAMSNewAmsterdam Pharma Company N.V.
AAPGAscentage Pharma Group International
SLNOSOLENO THERAPEUTICS INC